|David Shanahan, Chairman & CEO||
Mr. Shanahan has served as Chairman and is the Co-Founder of Gradalis, Inc. From 2004-2012, Mr. Shanahan served as President of Mary Crowley Cancer Research Centers, a cancer research non-profit specializing in clinical application of gene and immune therapies. Mary Crowley Cancer Centers have treated over 4,500 cancer patients in FDA-approved clinical trials, and Mr. Shanahan continues to serve as President Emeritus on the Mary Crowley Board of Trustees.
He is a named inventor on several U.S. patents and co-author of multiple peer-reviewed publications in the field of molecular therapeutics. Prior to his leadership at Mary Crowley, Mr. Shanahan served as the lead investor and founder of successful enterprises in a wide array of fields, many of which led to successful transactions of portfolio investments in the computer, commercial real estate and agricultural industries.
He obtained a B.S. in Electrical Engineering from Texas A&M University.